Orthofix Medical (OFIX) Invested Capital (2016 - 2025)
Orthofix Medical (OFIX) has disclosed Invested Capital for 16 consecutive years, with $450.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 10.55% year-over-year to $450.0 million, compared with a TTM value of $450.0 million through Dec 2025, down 10.55%, and an annual FY2025 reading of $450.0 million, down 10.55% over the prior year.
- Invested Capital was $450.0 million for Q4 2025 at Orthofix Medical, up from $442.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $664.2 million in Q1 2023 and bottomed at $333.5 million in Q3 2022.
- Average Invested Capital over 5 years is $463.7 million, with a median of $454.2 million recorded in 2025.
- The sharpest move saw Invested Capital soared 97.92% in 2023, then dropped 20.08% in 2025.
- Year by year, Invested Capital stood at $354.1 million in 2021, then decreased by 4.6% to $337.9 million in 2022, then soared by 77.58% to $600.0 million in 2023, then fell by 16.14% to $503.1 million in 2024, then decreased by 10.55% to $450.0 million in 2025.
- Business Quant data shows Invested Capital for OFIX at $450.0 million in Q4 2025, $442.5 million in Q3 2025, and $458.3 million in Q2 2025.